Rationale and design for a phase II trial of abobotulinumtoxinA (Dysport®) in the management of vulvodynia

Saved in:
Bibliographic Details
Published inToxicon (Oxford) Vol. 156; p. S40
Main Authors Goldstein, Andrew T., Catus, France, Picaut, Philippe
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.12.2018
Online AccessGet full text

Cover

More Information
ISSN:0041-0101
1879-3150
DOI:10.1016/j.toxicon.2018.11.098